Shivering Treatments for Targeted Temperature Management: A Review

Akash Jain, Maria Gray, Stephanie Slisz, Joseph Haymore, Neeraj Badjatia, Erik Kulstad

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Background: Shivering is common during targeted temperature management, and control of shivering can be challenging if clinicians are not familiar with the available options and recommended approaches. Purpose: The purpose of this review was to summarize the most relevant literature regarding various treatments available for control of shivering and suggest a recommended approach based on latest data. Methods: The electronic databases PubMed/MEDLINE and Google Scholar were used to identify studies for the literature review using the following keywords alone or in combination: "shivering treatment," "therapeutic hypothermia," "core temperature modulation devices," and "targeted temperature management." Results: Nonpharmacologic methods were found to have a very low adverse effect profile and ease of use but some limitations in complete control of shivering. Pharmacologic methods can effectively control shivering, but some have adverse effects, such that risks and benefits to the patient have to be balanced. Conclusion: An approach is provided which suggests that treatment for shivering control in targeted temperature management should be initiated before the onset of therapeutic hypothermia or prior to any attempt at lowering patient core temperature, with medications including acetaminophen, buspirone, and magnesium sulfate, ideally with the addition of skin counterwarming. After that, shivering intervention should be determined with the help of a shivering scale, and stepwise escalation can be implemented that balances shivering treatment with sedation, aiming to provide the most shivering reduction with the least sedating medications and reserving paralytics for the last line of treatment.

Original languageEnglish (US)
Pages (from-to)63-67
Number of pages5
JournalJournal of Neuroscience Nursing
Volume50
Issue number2
DOIs
StatePublished - Apr 1 2018

Fingerprint

Shivering
Temperature
Therapeutics
Induced Hypothermia
Buspirone
Magnesium Sulfate
PubMed
MEDLINE

Keywords

  • core temperature modulation devices
  • normothermia
  • shivering control in targeted temperature management
  • shivering control in TTM
  • shivering scale
  • shivering treatment
  • targeted temperature management
  • therapeutic hypothermia
  • therapeutic normothermia

ASJC Scopus subject areas

  • Surgery
  • Endocrine and Autonomic Systems
  • Clinical Neurology
  • Medical–Surgical

Cite this

Shivering Treatments for Targeted Temperature Management : A Review. / Jain, Akash; Gray, Maria; Slisz, Stephanie; Haymore, Joseph; Badjatia, Neeraj; Kulstad, Erik.

In: Journal of Neuroscience Nursing, Vol. 50, No. 2, 01.04.2018, p. 63-67.

Research output: Contribution to journalReview article

Jain, Akash ; Gray, Maria ; Slisz, Stephanie ; Haymore, Joseph ; Badjatia, Neeraj ; Kulstad, Erik. / Shivering Treatments for Targeted Temperature Management : A Review. In: Journal of Neuroscience Nursing. 2018 ; Vol. 50, No. 2. pp. 63-67.
@article{581c29a4784146f7a985e8681de3c094,
title = "Shivering Treatments for Targeted Temperature Management: A Review",
abstract = "Background: Shivering is common during targeted temperature management, and control of shivering can be challenging if clinicians are not familiar with the available options and recommended approaches. Purpose: The purpose of this review was to summarize the most relevant literature regarding various treatments available for control of shivering and suggest a recommended approach based on latest data. Methods: The electronic databases PubMed/MEDLINE and Google Scholar were used to identify studies for the literature review using the following keywords alone or in combination: {"}shivering treatment,{"} {"}therapeutic hypothermia,{"} {"}core temperature modulation devices,{"} and {"}targeted temperature management.{"} Results: Nonpharmacologic methods were found to have a very low adverse effect profile and ease of use but some limitations in complete control of shivering. Pharmacologic methods can effectively control shivering, but some have adverse effects, such that risks and benefits to the patient have to be balanced. Conclusion: An approach is provided which suggests that treatment for shivering control in targeted temperature management should be initiated before the onset of therapeutic hypothermia or prior to any attempt at lowering patient core temperature, with medications including acetaminophen, buspirone, and magnesium sulfate, ideally with the addition of skin counterwarming. After that, shivering intervention should be determined with the help of a shivering scale, and stepwise escalation can be implemented that balances shivering treatment with sedation, aiming to provide the most shivering reduction with the least sedating medications and reserving paralytics for the last line of treatment.",
keywords = "core temperature modulation devices, normothermia, shivering control in targeted temperature management, shivering control in TTM, shivering scale, shivering treatment, targeted temperature management, therapeutic hypothermia, therapeutic normothermia",
author = "Akash Jain and Maria Gray and Stephanie Slisz and Joseph Haymore and Neeraj Badjatia and Erik Kulstad",
year = "2018",
month = "4",
day = "1",
doi = "10.1097/JNN.0000000000000340",
language = "English (US)",
volume = "50",
pages = "63--67",
journal = "Journal of Neuroscience Nursing",
issn = "0888-0395",
publisher = "American Association of Neuroscience Nurses",
number = "2",

}

TY - JOUR

T1 - Shivering Treatments for Targeted Temperature Management

T2 - A Review

AU - Jain, Akash

AU - Gray, Maria

AU - Slisz, Stephanie

AU - Haymore, Joseph

AU - Badjatia, Neeraj

AU - Kulstad, Erik

PY - 2018/4/1

Y1 - 2018/4/1

N2 - Background: Shivering is common during targeted temperature management, and control of shivering can be challenging if clinicians are not familiar with the available options and recommended approaches. Purpose: The purpose of this review was to summarize the most relevant literature regarding various treatments available for control of shivering and suggest a recommended approach based on latest data. Methods: The electronic databases PubMed/MEDLINE and Google Scholar were used to identify studies for the literature review using the following keywords alone or in combination: "shivering treatment," "therapeutic hypothermia," "core temperature modulation devices," and "targeted temperature management." Results: Nonpharmacologic methods were found to have a very low adverse effect profile and ease of use but some limitations in complete control of shivering. Pharmacologic methods can effectively control shivering, but some have adverse effects, such that risks and benefits to the patient have to be balanced. Conclusion: An approach is provided which suggests that treatment for shivering control in targeted temperature management should be initiated before the onset of therapeutic hypothermia or prior to any attempt at lowering patient core temperature, with medications including acetaminophen, buspirone, and magnesium sulfate, ideally with the addition of skin counterwarming. After that, shivering intervention should be determined with the help of a shivering scale, and stepwise escalation can be implemented that balances shivering treatment with sedation, aiming to provide the most shivering reduction with the least sedating medications and reserving paralytics for the last line of treatment.

AB - Background: Shivering is common during targeted temperature management, and control of shivering can be challenging if clinicians are not familiar with the available options and recommended approaches. Purpose: The purpose of this review was to summarize the most relevant literature regarding various treatments available for control of shivering and suggest a recommended approach based on latest data. Methods: The electronic databases PubMed/MEDLINE and Google Scholar were used to identify studies for the literature review using the following keywords alone or in combination: "shivering treatment," "therapeutic hypothermia," "core temperature modulation devices," and "targeted temperature management." Results: Nonpharmacologic methods were found to have a very low adverse effect profile and ease of use but some limitations in complete control of shivering. Pharmacologic methods can effectively control shivering, but some have adverse effects, such that risks and benefits to the patient have to be balanced. Conclusion: An approach is provided which suggests that treatment for shivering control in targeted temperature management should be initiated before the onset of therapeutic hypothermia or prior to any attempt at lowering patient core temperature, with medications including acetaminophen, buspirone, and magnesium sulfate, ideally with the addition of skin counterwarming. After that, shivering intervention should be determined with the help of a shivering scale, and stepwise escalation can be implemented that balances shivering treatment with sedation, aiming to provide the most shivering reduction with the least sedating medications and reserving paralytics for the last line of treatment.

KW - core temperature modulation devices

KW - normothermia

KW - shivering control in targeted temperature management

KW - shivering control in TTM

KW - shivering scale

KW - shivering treatment

KW - targeted temperature management

KW - therapeutic hypothermia

KW - therapeutic normothermia

UR - http://www.scopus.com/inward/record.url?scp=85044054331&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044054331&partnerID=8YFLogxK

U2 - 10.1097/JNN.0000000000000340

DO - 10.1097/JNN.0000000000000340

M3 - Review article

C2 - 29278601

AN - SCOPUS:85044054331

VL - 50

SP - 63

EP - 67

JO - Journal of Neuroscience Nursing

JF - Journal of Neuroscience Nursing

SN - 0888-0395

IS - 2

ER -